Management guidelines for hyperthyroidism

Allannic, 1990, Antithyroid drugs and Graves' disease: a prospective randomized evaluation of the efficacy of treatment duration, Journal of Clinical Endocrinology and Metabolism, 70, 675, 10.1210/jcem-70-3-675 Barnes, 1972, A simple test for selecting the thionamide schedule in thyrotoxicosis, Journal of Clinical Endocrinology and Metabolism, 35, 250, 10.1210/jcem-35-2-250 Bartalena, 1989, Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism, New England Journal of Medicine, 321, 1349, 10.1056/NEJM198911163212001 Baxter, 1993, Radioiodine therapy for hyperthyroidism in young patients-perception of risk and use, Quarterly Journal of Medicine, 86, 495, 10.1093/qjmed/86.8.495 Dahlberg, 1981, Studies of thyroid hormone and methimazole levels in patients with Graves' disease on a standardized antithyroid drug regimen, Clinical Endocrinology, 14, 555, 10.1111/j.1365-2265.1981.tb02965.x Degroot, 1995, Radiation and Graves' ophthalmopathy, Journal of Clinical Endocrinology and Metabolism, 80, 339, 10.1210/jc.80.2.339 Dobyns, 1974, Malignant and benign neoplasms of the thyroid in patients treated for hyperthyroidism: a report of the co-operative thyrotoxicosis therapy follow-up study, Journal of Clinical Endocrinology and Metabolism, 38, 976, 10.1210/jcem-38-6-976 Falk, 1990, The management of hyperthyroidism—a surgeon's perspective, Otolaryngology Clinics of North America, 23, 361, 10.1016/S0030-6665(20)31262-7 Feek, 1980, Combination of potassium iodide and propranolol in preparation of patients with Graves' disease for thyroid surgery, New England Journal of Medicine, 302, 883, 10.1056/NEJM198004173021602 Franklyn, 1994, The management of hyperthyroidism, New England Journal of Medicine, 330, 1731, 10.1056/NEJM199406163302407 Franklyn, 1991, Long-term follow-up of treatment of thyrotoxicosis by three different methods, Clinical Endocrinology, 34, 71, 10.1111/j.1365-2265.1991.tb01738.x Goldman, 1988, Radioactive iodine therapy and breast cancer, American Journal of Epidemiology, 127, 961, 10.1093/oxfordjournals.aje.a114900 Greer, 1977, Short-term antithyroid drug therapy for thyrotoxicosis of Graves's disease, New England Journal of Medicine, 297, 173, 10.1056/NEJM197707282970401 Hall, 1992, Leukaemia incidence after iodine-131 exposure, Lancet, 340, 1, 10.1016/0140-6736(92)92421-B Hedley, 1983, Late onset hypothyroidism after subtotal thyroidectomy for hyperthyroidism: implications for long-term follow-up, British Journal of Surgery, 70, 740, 10.1002/bjs.1800701215 Hedley, 1989, Antithyroid drugs in the treatment of hyperthyroidism of Graves' disease: long term follow up of 434 patients, Clinical Endocrinology, 31, 209, 10.1111/j.1365-2265.1989.tb01244.x Hershman, 1966, The treatment of hyperthyroidism, Annals of Internal Medicine, 64, 1306, 10.7326/0003-4819-64-6-1306 Holm, 1991, Cancer risk after iodine-131 therapy for hyperthyroidism, Journal of the National Cancer Institute, 83, 1072, 10.1093/jnci/83.15.1072 Lazarus, 1995, Guidelines for the use of radioactive iodine in the management of hyperthyroidism, Journal of the Royal College of Physicians of London, 29, 464 Lippe, 1987, Hyperthyroidism in children treated with long term medical therapy: twenty-five percent remission every two years, Journal of Clinical Endocrinology and Metabolism, 64, 1241, 10.1210/jcem-64-6-1241 Mashio, 1988, Treatment of hyperthyroidism with a small single daily dose of methimazole, Acta Endocrinologica, 119, 139, 10.1530/acta.0.1190139 Okamura, 1987, Reevaluation of the effects of methylmercaptoimidazole and propylthiouracil in patients with Graves' hyperthyroidism, Journal of Clinical Endocrinology and Metabolism, 65, 719, 10.1210/jcem-65-4-719 Ready, 1994, Complications of thyroidectomy, British Journal of Surgery, 81, 1555, 10.1002/bjs.1800811103 Reinwein, 1993, A prospective randomized trial of antithyroid drug dose in Graves' disease therapy, Journal of Clinical Endocrinology and Metabolism, 76, 1516, 10.1210/jc.76.6.1516 Schleusener, 1989, Prospective multicentre study on the prediction of relapse after antithyroid drug treatment in patients with Graves' disease, Acta Endocrinologica, 120, 689, 10.1530/acta.0.1200689 Singer, 1994, Treatment guidelines for patients with hyperthyroidism and hypothyroidism, Journal of the American Medical Association, 273, 808, 10.1001/jama.1995.03520340064038 Sridama, 1989, Treatment of Graves' disease and the course of ophthalmopathy, American Journal of Medicine, 87, 70, 10.1016/S0002-9343(89)80485-1 Sridama, 1984, Long-term follow-up study of compensated low dose 131I therapy, New England Journal of Medicine, 311, 426, 10.1056/NEJM198408163110702 Sugrue, 1980, Hyperthyroidism in the land of Graves': results of treatment by surgery, radioiodine and carbimazole in 837 cases, Quarterly Journal of Medicine, 49, 51 Tallstedt, 1992, Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism, New England Journal of Medicine, 326, 1733, 10.1056/NEJM199206253262603 Tamai, 1980, Thionamide therapy in Graves' disease-relation of relapse rate to duration of therapy, Annals of Internal Medicine, 92, 488, 10.7326/0003-4819-92-4-488 Tunbridge, 1977, The spectrum of thyroid disease in a community: the Whickham survey, Clinical Endocrinology, 7, 481, 10.1111/j.1365-2265.1977.tb01340.x Turner, 1985, Radioiodine therapy for Graves' disease: multivariate analysis of pretreatment parameters and early outcome, European Journal of Nuclear Medicine, 11, 191, 10.1007/BF00279066 Vanderpump, 1996, Consensus statement for good practice and audit measures in the management of hypothyroidism and hyperthyroidism, British Medical Journal, 313, 539, 10.1136/bmj.313.7056.539 Wartofsky, 1991, Differences and similarities in the diagnosis and treatment of Graves' disease in Europe, Japan and the United States, Thyroid, 1, 129, 10.1089/thy.1991.1.129 Watson, 1988, Outcome following standardized 185 MBq dose 131I therapy for Graves' disease, Clinical Endocrinology, 28, 487, 10.1111/j.1365-2265.1988.tb03683.x Weetman, 1994, Treatment of Graves' disease with the block replace regimen of antithyroid drugs: the effect of treatment duration and immunogenetic susceptibility on relapse, Quarterly Journal of Medicine, 87, 337 Wilson, 1986, The ability of the serum thyrotrophin receptor antibody (TRAb) index and HLA-status to predict long-term remission of thyrotoxicosis following medical therapy for Graves' disease, Clinical Endocrinology, 25, 151, 10.1111/j.1365-2265.1986.tb01676.x Wise, 1973, Single-dose, ‘block-replace’ drug therapy in hyperthyroidism, British Medical Journal, iv, 143, 10.1136/bmj.4.5885.143 Young, 1988, Prediction of remission after antithyroid drug treatment in Graves' disease, Quarterly Journal of Medicine, 66, 175